CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,403,032
- in 5 filings, $2.4M under 10b5-1 plans
Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-02-09 | Asam Alexander Director | Grant or award · Stock Option | +44,000 | 44,000 | ||
| 2023-02-09 | Congleton Jon Chief Executive Officer | Grant or award · Stock Option | +250,046 | 250,046 | ||
| 2023-02-09 | Levy Adam Scott CFO, Chief Bus. Off. and Secy. | Grant or award · Stock Option | +97,518 | 97,518 | ||
| 2023-02-09 | Rodman David Malcom Chief Medical Officer | Grant or award · Stock Option | +104,186 | 104,186 | ||
| 2023-02-09 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option | +44,000 | 44,000 |
Page 23 of 23 · 446 trades